1. Cohen AH, Adler SG . Nail-patella syndrome (osteo-onychodysplasia), lipodystrophy, Fabry's disease (angiokeratoma corporis diffusum universale), and familial lecithin-cholesterol acyltransferase deficiency. In: Tisher CC, Brenner BM (eds). Renal Pathology, 2nd edn. Lippincott Company: Philadelphia, 1994, pp 1267–1289.
2. Bernstein J, Churg J . Heritable metabolic diseases. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney, 5th edn. Lippincott-Raven Publishers: Philadelphia, 1998, pp 1287–1320.
3. Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine 2002;81:122–138.
4. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138:338–346.
5. Nakao S, Kodama C, Takenaka T, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a ‘renal variant’. Kidney Int 2003;64:801–807.